English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 26 Help

Selected(0)Clear Items/Page:    Sort:
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products Journal article
Zhang, Le Le, Zhang, Du Juan, Shi, Jia Xin, Huang, Mu Yang, Yu, Jia Mei, Chen, Xu Jia, Wei, Xiao, Zou, Liang, Lu, Jin Jian. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products[J]. Phytomedicine, 2024, 132, 155828.
Authors:  Zhang, Le Le;  Zhang, Du Juan;  Shi, Jia Xin;  Huang, Mu Yang;  Yu, Jia Mei; et al.
Favorite | TC[Scopus]:1  IF:6.7/6.2 | Submit date：2024/07/04
Cancer Therapy  Immunogenic Cell Death  Natural Products  Regulated Cell Death  Tumor Immune Microenvironment  
Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer Journal article
Wang, Xianzhe, Shi, Wei, Wang, Xumei, Lu, Jin Jian, He, Ping, Zhang, Hongjie, Chen, Xiuping. Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer[J]. Cell Death Discovery, 2023, 9(1), 355.
Authors:  Wang, Xianzhe;  Shi, Wei;  Wang, Xumei;  Lu, Jin Jian;  He, Ping; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:6.1/6.0 | Submit date：2024/01/02
Tetrastigma hemsleyanum polysaccharide enhances the anti-cancer efficacy of PD-L1 antibody by modulating the tumor microenvironment Conference paper
Chen, Yuchi, Huang, Muyang, Shi, Wei, Yu, Weibang, Huang, Canyu, Ding, Zhishan, Lu, Jinjian. Tetrastigma hemsleyanum polysaccharide enhances the anti-cancer efficacy of PD-L1 antibody by modulating the tumor microenvironment[C], 2022.
Authors:  Chen, Yuchi;  Huang, Muyang;  Shi, Wei;  Yu, Weibang;  Huang, Canyu; et al.
Favorite |  | Submit date：2023/08/25
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date：2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib  
Anti-proliferative cassane-type diterpenoids from the seeds of Caesalpinia minax Journal article
Xu,Yunshao, Shi,Wei, Feng,Lu, Cao,Jun, Feng,Zheling, Zhang,Qingwen, Lu,Jinjian, Ye,Yang, Lin,Ligen. Anti-proliferative cassane-type diterpenoids from the seeds of Caesalpinia minax[J]. Natural Product Research, 2022, 36(4), 932-941.
Authors:  Xu,Yunshao;  Shi,Wei;  Feng,Lu;  Cao,Jun;  Feng,Zheling; et al.
Favorite | TC[WOS]:7 TC[Scopus]:8  IF:1.9/2.1 | Submit date：2021/03/01
Caesalpinia Minax  Fabaceae  Cassane Diterpenoids  Cytotoxic Activity  
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies Journal article
Shi, Wei, Qi, Lu, You, Xiong Bin, Chen, Yu Chi, Xu, Yu Lian, Yu, Wei Bang, Huang, Mu Yang, Zhao, Hong, Lu, Jin Jian. Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies[J]. Current Cancer Drug Targets, 2022, 22(2), 142-152.
Authors:  Shi, Wei;  Qi, Lu;  You, Xiong Bin;  Chen, Yu Chi;  Xu, Yu Lian; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:2.3/3.1 | Submit date：2022/06/14
Ahsa1  Breast Cancer  Invasion  Migration  Network Pharmacology  Shenling Baizhu Powder  
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells Journal article
Chen, Yu Chi, He, Xin Ling, Qi, Lu, Shi, Wei, Yuan, Luo Wei, Huang, Mu Yang, Xu, Yu Lian, Chen, Xiuping, Gu, Lei, Zhang, Le Le, Lu, Jin Jian. Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells[J]. Biochemical Pharmacology, 2022, 197, 114940.
Authors:  Chen, Yu Chi;  He, Xin Ling;  Qi, Lu;  Shi, Wei;  Yuan, Luo Wei; et al.
Favorite | TC[WOS]:20 TC[Scopus]:22  IF:5.3/5.2 | Submit date：2022/03/28
Indoleamine 2, 3-dioxygenase 1  Interferon-γ  Lung Cancer  Myricetin  Programmed Death Ligand-1  
Anticancer Effects of Ginsenoside Rh2: A Systematic Review Journal article
He, Xin Ling, Xu, Xiao Huang, Shi, Jia Jie, Huang, Mingqing, Wang, Yitao, Chen, Xiuping, Lu, Jin Jian. Anticancer Effects of Ginsenoside Rh2: A Systematic Review[J]. Current Molecular Pharmacology, 2022, 15(1), 179-189.
Authors:  He, Xin Ling;  Xu, Xiao Huang;  Shi, Jia Jie;  Huang, Mingqing;  Wang, Yitao; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.4/2.8 | Submit date：2022/02/21
Cancer  Cytotoxicity  Ginseng  Ginsenoside Rh2  Mechanism  Natural Compound  
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Journal article
Chen, Yu Chi, Shi, Wei, Shi, Jia Jie, Lu, Jin Jian. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148(1), 1-14.
Authors:  Chen, Yu Chi;  Shi, Wei;  Shi, Jia Jie;  Lu, Jin Jian
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:2.7/3.1 | Submit date：2022/02/21
Anemia  Cd47/sirpα  Immunotherapy  Macrophages  Phagocytosis Checkpoint  
Cassane-Type Diterpenoids from the Seeds of Caesalpinia bonduc (L.) Roxb. Journal article
Cao, Jun, Xu, Yunshao, Lou, Ruohan, Shi, Wei, Chen, Jiali, Gan, Lishe, Lu, Jinjian, Lin, Ligen. Cassane-Type Diterpenoids from the Seeds of Caesalpinia bonduc (L.) Roxb.[J]. CHEMISTRY & BIODIVERSITY, 2021, 18(9), e2100309.
Authors:  Cao, Jun;  Xu, Yunshao;  Lou, Ruohan;  Shi, Wei;  Chen, Jiali; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.3/2.5 | Submit date：2021/12/08
Absolute Configurations  Caesalpinia Bonduc  Cassane-type Diterpenoids  Ecd  Fabaceae